Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis-Reference-Cited by-同舟云学术

Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis

Published:2024-02-16 Issue:1 Volume:56 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Basagaña Maria¹^ORCID,Martínez-Rivera Carlos²^ORCID,Padró Clara¹^ORCID,Garcia-Olivé Ignasi²^ORCID,Martínez-Colls Mimar³^ORCID,Navarro Juan³,Pardo Laura⁴^ORCID,Cruz Paula⁴,Cardona Peitx Gloria⁵,Carabias Lídia⁵,Roger Albert¹,Abad Jorge²,Rosell Antoni²^ORCID

Affiliation:

1. Allergy Section, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain

2. Pneumology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain

3. Pediatric Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain

4. Otorhinolaryngology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain

5. Pharmacy Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2317356

Reference40 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

2. Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain;Quirce S;J Investig Allergol Clin Immunol,2011

3. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

4. Cluster Analysis and Clinical Asthma Phenotypes

5. Asthma phenotypes: the evolution from clinical to molecular approaches